PATENT CLAIM ANALYSIS

Application Number: 15885333
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "232800"]

Abstract:
Disclosed herein are compounds, pharmaceutical compositions, and related methods for the treatment of viral infection, including RNA viral infection in subjects. The compounds, pharmaceutical compositions, and methods can modulate the innate immune antiviral response in vertebrate cells, including activating the RIG-I pathway.

Claim (Index 36):
The method of  claim 34  wherein the cell is in vitro.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.51515
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13765583', '14348516', '15419784', '13640732', '14391638']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.819882169594326
- 35 USC 102 Novelty (BERT): 0.5432689626861551
- Combined Prediction Score: 0.792220848903509
- Mean Citation Score: 353.882134
- Max Citation Score: 386.89203
- Similarity Product: 305.8726656573164

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test